Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA rejection
Pharma
Xspray hits FDA wall with new manufacturing-related rejection
It's the third FDA complete response letter for Xspray during its repeated attempts to launch Dasynoc, a leukemia med based on a BMS' blockbuster.
Zoey Becker
Oct 9, 2025 9:23am
Fierce Biotech
FDA snubs Fortress' Zydus-partnered Menkes disease candidate
Oct 1, 2025 12:00pm
Biogen undeterred after FDA snub for high-dose Spinraza in SMA
Sep 24, 2025 9:51am
Otsuka, Lundbeck's Rexulti snubbed by FDA in PTSD
Sep 22, 2025 4:42pm
FDA's response letter salvo sheds light on drug refusal process
Jul 11, 2025 10:15am
Regeneron's Eylea franchise stumbles on several fronts in Q1
Apr 29, 2025 2:50pm